IRIS

1.1 Articolo in rivista: [36184] Home page tipologia

Sfoglia
Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 12.501 a 12.520 di 36.184
Titolo Data di pubblicazione Autore(i) File
High-dose mitoxantrone + melphalan (MITO/L-PAM) as conditioning regimen supported by peripheral blood progenitor cell (PBPC) autograft in 113 lymphoma patients: high tolerability with reversible cardiotoxicity 1-gen-2001 Tarella, C; Zallio, F; Caracciolo, D; Cuttica, A; Corradini, P; Gavarotti, P; Ladetto, M; Podio, V; Sargiotto, A; Rossi, G; Gianni, Am; Pileri, A
A validated real-time quantitative PCR approach shows a correlation between tumor burden and successful ex vivo purging in follicular lymphoma patients 1-gen-2001 Ladetto, M.; S, Sametti; Jw, Donovan; D, Ferrero; M, Astolfi; M, Mitterer; I, Ricca; D, Drandi; P, Corradini; P, Coser; A, Pileri; Jg, Gribben; C., Tarella
Concurrent administration of high-dose chemotherapy and rituximab is a feasible and effective chemo/immunotherapy for patients with high-risk non-Hodgkin's lymphoma 1-gen-2001 Ladetto, Marco; Zallio, F; Vallet, S; Ricca, I; Cuttica, A; Caracciolo, D; Corradini, P; Astolfi, Monica; Sametti, S; Volpato, F; Bondesan, P; Vitolo, U; Boccadoro, Mario; Pileri, A; Gianni, Am; Tarella, Corrado
High-dose sequential (HDS) chemotherapy for high-risk non-Hodgkin's lymphoma: long-term analysis and future developments 1-gen-2001 Tarella, Corrado; Cuttica, A; Caracciolo, D; Pileri, Alessandro; Ricca, I; Bergui, L; Gavarotti, P; Marinone, C; Pagano, M; Rossi, G; DE CRESCENZO, A; Salomone, A; Ladetto, Marco; Boccadoro, Mario; Pileri, A.
Immunoglobulin heavy-chain consensus probes for real-time PCR quantification of residual disease in acute lymphoblastic leukemia 1-gen-2000 Donovan, J. W.; Ladetto, M.; Zou, G.; Neuberg, D.; Poor, C.; Bowers, D.; Gribben, J. G.
Immunoglobulin framework-derived peptides function as cytotoxic T-cell epitopes commonly expressed in B-cell malignancies 1-gen-2000 Trojan, A; Schultze, Jl; Witzens, M; Vonderheide, Rh; Ladetto, M; Donovan, Jw; Gribben, Jg
Predictors of intubation in COVID-19 patients treated with out-of-ICU continuous positive airway pressure 1-gen-2021 De Vita, N; Scotti, L; Cammarota, G; Racca, F; Pissaia, C; Maestrone, C; Colombo, D; Olivieri, C; Della Corte, F; Barone-Adesi, F; Navalesi, P; Vaschetto, R
Real-Time polymerase chain reaction of immunoglobulin rearrangements for quantitative evaluation of minimal residual disease in multiple myeloma 1-gen-2000 Ladetto, M.; Jw, Donovan; S, Harig; A, Trojan; C, Poor; R, Schlossnan; Kc, Anderson; Jg., Gribben
Long-term follow-up of advanced-stage low-grade lymphoma patients treated upfront with high-dose sequential chemotherapy and autograft 1-gen-2000 Tarella, C.; Caracciolo, D.; Corradini, P.; Zallio, F.; Ladetto, M.; Cuttica, A.; Rossi, G.; Novero, D.; Gavarotti, P.; Pileri, A.
Clinical relevance of minimal residual disease monitoring in non-Hodgkin's lymphomas: a critical reappraisal of molecular strategies 1-gen-1999 P, Corradini; Ladetto, M.; A, Pileri; C., Tarella
Negative immunomagnetic ex vivo purging combined with high-dose chemotherapy with peripheral blood progenitor cell autograft in follicular lymphoma patients: evidence for long-term clinical and molecular remissions 1-gen-1999 C, Tarella; P, Corradini; M, Astolfi; P, Bondesan; D, Caracciolo; C, Cherasco; Ladetto, M.; F, Giaretta; I, Ricca; U, Vitolo; A, Pileri; D, Ferrero
Clinical and molecular remission after allogeneic blood cell transplantation in a patient with mantle-cell lymphoma 1-gen-1996 Corradini, P; Ladetto, Marco; Astolfi, M; Voena, C; Tarella, Corrado; Bacigalupo, A; Pileri, Alessandro
N- and K-ras oncogenes in plasma cell dyscrasias 1-gen-1994 Corradini, P; Ladetto, M; Inghirami, G; Boccadoro, M; Pileri, A
Inactivation of tumor suppressor genes, p53 and Rb1, in plasma cell dyscrasias 1-gen-1994 Corradini, P; Inghirami, G; Astolfi, M; Ladetto, M; Voena, C; Ballerini, P; Gu, W; Nilsson, K; Knowles, Dm; Boccadoro, M; Pileri, A; DALLA FAVERA, R
Major Tumor Shrinking and Persistent Molecular Remissions After Consolidation With Bortezomib, Thalidomide, and Dexamethasone in Patients With Autografted Myeloma 1-gen-2010 Ladetto, Marco; Pagliano, GLORIA TOMMASINA; Ferrero, Simone; Cavallo, Federica; Drandi, Daniela; L., Santo; C., Crippa; L., De Rosa; P., Pregno; M., Grasso; A. M., Liberati; T., Caravita; F., Pisani; T., Guglielmelli; V., Callea; P., Musto; C., Cangialosi; R., Passera; Boccadoro, Mario; Palumbo, Antonio
Stem cell transplantation in multiple myeloma and other plasma cell disorders (report from an EBMT preceptorship meeting) 1-gen-2016 Bruno, Benedetto; Auner, Holger W; Gahrton, Gösta; Garderet, Laurent; Festuccia, MORENO BENEDETTO; Ladetto, Marco; Lemoli, Roberto M; Massaia, Massimo; Morris, Curly; Palumbo, Antonio; Schönland, Stefan; Boccadoro, Mario; Kröger, Nicolaus
The new tumor-suppressor gene inhibitor of growth family member 4 (ING4) regulates the production of proangiogenic molecules by myeloma cells and suppresses hypoxia-inducible factor-1 {alpha} (HIF-1{alpha}) activity: involvement in myeloma-induced angioge 1-gen-2007 Colla, S; Tagliaferri, S; Morandi, F; Lunghi, P; Donofrio, G; Martorana, D; Mancini, C; Lazzaretti, M; Mazzera, L; Ravanetti, L; Bonomini, S; Ferrari, L; Miranda, C; Ladetto, Marco; Neri, Tm; Neri, A; Greco, A; Mangoni, M; Bonati, A; Rizzoli, V; Giuliani, N.
Long-term molecular remission after conventional chemotherapy in a patient with Philadelphia-negative acute lymphoblastic leukemia 1-gen-1996 Ladetto, M; Corradini, P; Astolfi, M; Campana, S; Tarella, C; Pileri, A
Thirty-month complete response as a surrogate end point in first-line follicular lymphoma therapy: An individual patient-level analysis of multiple randomized trials 1-gen-2017 Shi, Q.; Flowers, C. R.; Hiddemann, W.; Marcus, R.; Herold, M.; Hagenbeek, A.; Kimby, E.; Hochster, H.; Vitolo, U.; Peterson, B. A.; Gyan, E.; Ghielmini, M.; Nielsen, T.; De Bedout, S.; Fu, T.; Valente, N.; Fowler, N. H.; Hoster, E.; Ladetto, M.; Morschhauser, F.; Zucca, E.; Salles, G.; Sargent, D. J.
Interim 18-FDG-PET/CT failed to predict the outcome in diffuse large B-cell lymphoma patients treated at the diagnosis with rituximab-CHOP 1-gen-2012 Pregno, P; Chiappella, A; Bellò, M; Botto, B; Ferrero, S; Franceschetti, S; Giunta, F; Ladetto, M; Limerutti, G; Menga, M; Nicolosi, M; Priolo, G; Puccini, B; Rigacci, L; Salvi, F; Vaggelli, L; Passera, R; Bisi, G; Vitolo, U
Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 12.501 a 12.520 di 36.184
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile

Scopri
Tipologia
  • 1 Contributo su Rivista36183
  • 4 Contributo in Atti di Convegno ...1
Autore
  • ARNEODO, Michele1426
  • ARCIDIACONO, Roberta1411
  • RUSPA, Marta1323
  • GAIDANO, Gianluca767
  • RAMELLO, Luciano682
  • SITTA, Mario630
  • CORTESE, Pietro622
  • SACERDOTE, Carlotta548
  • Patti, Giuseppe Rocco Salvatore429
  • PIRISI, Mario412
Data di pubblicazione
  • In corso di stampa64
  • 2020 - 20269921
  • 2010 - 201913042
  • 2000 - 20097282
  • 1990 - 19994152
  • 1980 - 19891467
  • 1970 - 1979232
  • 1962 - 196924
Rivista
  • PHYSICS LETTERS. SECTION B771
  • JOURNAL OF HIGH ENERGY PHYSICS499
  • PHYSICAL REVIEW LETTERS295
  • THE EUROPEAN PHYSICAL JOURNAL. C,...284
  • PHYSICAL REVIEW D234
  • JOURNAL OF HIGH ENERGY PHYSICS183
  • PLOS ONE181
  • BLOOD169
  • INTERNATIONAL JOURNAL OF MOLECULA...164
  • NUCLEAR INSTRUMENTS & METHODS IN ...145
Keyword
  • Humans1437
  • Female757
  • Male607
  • Middle Aged459
  • Adult415
  • Aged406
  • COVID-19344
  • Italy298
  • Animals217
  • Treatment Outcome196
Lingua
  • eng24781
  • ita5291
  • fre259
  • spa169
  • ger58
  • rus29
  • und26
  • por17
  • lat15
  • grc6
Accesso al fulltext
  • no fulltext21433
  • reserved7318
  • open4981
  • restricted2336
  • partially open90
  • embargoed17
  • mixed9